- Joined
- Nov 21, 1998
- Messages
- 12,530
- Reaction score
- 6,917
https://clinicaltrials.gov/ct2/show/NCT02412735?term=NCT02412735&rank=1
Interesting phase III testing of an investigational treatment for chronic low back pain associated with degenerative disc disease. The study will test the use of Mesenchymal Precursor Cells (MPCs) – adult stem cells derived from bone marrow that will be directly injected into the lumbar disc. Once enrolled, patients are randomly assigned to one of three treatment groups:
Interesting phase III testing of an investigational treatment for chronic low back pain associated with degenerative disc disease. The study will test the use of Mesenchymal Precursor Cells (MPCs) – adult stem cells derived from bone marrow that will be directly injected into the lumbar disc. Once enrolled, patients are randomly assigned to one of three treatment groups:
- One third (1/3) will receive a 6 million cell dose of MPCs, plus hyaluronic acid, a substance that facilitates the localization and retention of the stem cells;
- One third (1/3) will receive a 6 million cell dose of MPCs alone;
- One third (1/3) will receive only the saline solution.